The current price-to-earnings ratio of XRAY can't be determined, as the TTM EPS of -$4.76 is negative. The last PE ratio of DENTSPLY SIRONA, recorded in June 2022, was 22.47.
The PE ratio of DENTSPLY SIRONA has averaged 39.68 over the last ten years. In the past ten years, XRAY's PE ratio reached its highest point in the Jun 2019 quarter at 126.87, when the stock price was $58.36 and the EPS was $0.46. The lowest point was recorded in the Sep 2013 quarter, when it reached 16.89 with a price of $43.42 and an EPS of $2.57.
Maximum annual increase: 45.51% in 2015
Maximum annual decrease: -13.8% in 2016
| Year | PE ratio | Change |
|---|---|---|
| 2022 | N/A | N/A |
| 2021 | 29.68 | N/A |
| 2020 | N/A | N/A |
| 2019 | 49.21 | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | 29.3 | -13.8% |
| 2015 | 33.99 | 45.51% |
| 2014 | 23.36 | 5.99% |
| 2013 | 22.04 | 23.54% |
| Stock name | PE ratio | Market cap |
|---|---|---|
| PDEX Pro Dex Inc | 11.88 | $55.17M |
| IART Integra Lifesciences Holdings Corp | 24.12 | $3.12B |
| DHR Danaher Corp | 28.76 | $183.28B |
| ALGN Align Technology Inc | 75.89 | $23.64B |
| BIOL Biolase Inc | N/A | $1.88M |
| MMM 3M Co | N/A | $51.76B |
| XRAY DENTSPLY SIRONA Inc | N/A | $7.31B |
The current price to earnings ratio of XRAY can't be calculated, as its EPS of -$4.76 is negative.
As an average over the last 3 years, XRAY stock has a PE ratio of 39.06.
As an average over the last 5 years, XRAY stock has a PE ratio of 59.98.
The highest quarterly PE ratio in the last ten years has been 126.87 and it was in the Jun 2019 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.